Custom Assay Development

About AssayGate

AssayGate, Inc. is a specialized bioanalytical service provider dedicated to delivering comprehensive and cost-effective biomarker testing with a focus on scientific integrity and client collaboration. With over 20 years of collective experience, its team of PhD scientists develops custom assays and provides validated testing services across multiple high-performance platforms, including Olink, Simoa, and MSD-ECL. The company operates as an Olink Certified Laboratory and partners with technology leaders like Quanterix to support pharmaceutical and biotech clients in translational medicine and biomarker discovery.

About TissueVision

TissueVision is a private, revenue-generating contract research organization (CRO) focused on high-resolution 3D whole-tissue imaging and analysis. The company's core technology is its TissueCyte® imaging platform, which automates tissue sectioning and multi-spectral imaging to generate terabytes of quantitative data per study, enabling large-scale projects in neuroscience, oncology, and fibrosis. With a strong foundation from MIT and NIH grant support, TissueVision serves as a critical partner for clients needing scalable, statistically powerful histological data to advance therapeutic programs from discovery through preclinical development.

About Wasatch BioLabs

Wasatch BioLabs is a specialized service provider in the genetics and genomics sector, built around proprietary long-read sequencing platforms for integrated genomic and epigenomic data. Its core innovation is the Direct Whole Methylome Sequencing (dWMS) platform, which enables bisulfite-free, PCR-free methylation analysis alongside variant detection. Positioning itself as the first full-scale clinical lab dedicated to Oxford Nanopore sequencing, the company targets the high-growth areas of precision health, biomarker discovery, and scalable clinical assay deployment.

About Primerdesign

Primerdesign Ltd., a subsidiary of the Novacyt Group, is a specialized molecular diagnostics company focused on the commercialization of real-time qPCR assays and integrated workflows. With over 20 years of collective expertise, the company has developed over 1,200 assays and serves customers in over 100 countries through a global distributor network. Its strategy leverages an open-platform, instrument-agnostic approach to provide flexible, high-performance detection solutions for human health, food safety, and animal health markets.

About Intuitive Biosciences

Intuitive Biosciences is a private, revenue-generating diagnostics and services company serving the biomedical research market, particularly in non-human primate studies. The company leverages its immunoassay development platform to offer custom assay development, validated screening tests, and multiplexed panels capable of measuring 1 to 100 markers per well. With a small, expert-led team, it provides end-to-end support from proof-of-concept to manufacturing, catering to research labs that require specialized infectious disease diagnostics. Its business model combines fee-for-service work with product sales, establishing a niche in the preclinical research supply chain.

Therapeutic Areas

Other Client-specific research needs Drugs